We are a biopharmaceutical company focused on discovering, developing and commercializing novel drugs that target G protein-coupled receptors (GPCRs) to address unmet medical needs.

Research Grants show all

NIH23

Publications show all

Arena Pharmaceuticals has published 104 articles.

Patents show all

Arena Pharmaceuticals has 2 licensable patents.
275Applications269Issued

Clinical Trials show all

14Phase 213Phase 13Phase 31Other

SEC Filings show all

8-K27510-Q5410-K18D2S-11

Overview

Total FundingEmployeesLast Funding DateStatus
$334,660,000251-5002017-04-24Ipo

Crunchbase Investment Rounds

DateAmountRoundValuationLead InvestorOther Investors
2012-01-11$33,000,000Post Ipo Equity
2003-12-24$35,000,000Series Unknown
2017-04-24$79,400,000Post Ipo Equity
2010-06-03$35,500,000Post Ipo EquityDeerfield Capital Management
2009-06-17$151,760,000Post Ipo EquityDeerfield Capital Management

SEC Form D Funding Events

DateOfferedSoldType
2010-06-21$35,530,000$35,530,000Equity
2009-07-21$151,760,000$151,760,000Option to Acquire, Security to be Acquired

Key Executives

  • Jack Lief
    Executive Officer, Director
  • K.a. Ajit-simh
    Executive Officer
  • Dominic P. Behan
    Executive Officer, Director
  • Robert E. Hoffman
    Executive Officer
  • William R. Shanahan, Jr.
    Executive Officer
  • Steven W. Spector
    Executive Officer
  • Donald D. Belcher
    Director
  • Scott H. Bice
    Director
  • Harry F. Hixson, Jr.
    Director
  • J. Clayburn La Force, Jr.
    Director
  • Tina S. Nova
    Director
  • Phillip M. Schneider
    Director
  • Christine A. White
    Director
  • Randall E. Woods
    Director